Company intelligence / Profile preview

GD Kongming Biotech

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Kongming Biotech is a biotechnology company based in Guangdong, China, specializing in drug discovery and development services. The company focuses on providing high-throughput screening, medicinal chemistry, and lead optimization services to pharmaceutical and biotech partners. Kongming Biotech leverages its proprietary technology platforms to accelerate the identification of novel therapeutic candidates across various modalities, including small molecules and peptides. Their business model combines internal research and development with contract research organization (CRO) services to support the global life sciences industry.

Modalities: Small moleculePeptidesAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on GD Kongming Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GD Kongming Biotech.

Explore the full profile